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Abstract
 
Natural killer (NK) cells play a critical role in the innate immune response against cytomeg-
alovirus (CMV) infections. Although CMV encodes several gene products committed to
evasion of adaptive immunity, viral modulation of NK cell activity is only beginning to be
appreciated. A previous study demonstrated that the mouse CMV m152-encoded gp40 glyco-
protein diminished expression of ligands for the activating NK cell receptor NKG2D on the
surface of virus-infected cells. Here we have defined the precise ligands that are affected and
have directly implicated NKG2D in immune responses to CMV infection in vitro and in vivo.
Murine CMV (MCMV) infection potently induced transcription of all five known retinoic
 
acid early inducible 1 (
 
RAE-1
 
)
 
 
 
genes (
 
RAE-1
 
 
 
, 
 
RAE-1
 
 
 
, 
 
RAE-1
 
 
 
, 
 
RAE-1
 
 
 
, and 
 
RAE-1
 
 
 
),
but not 
 
H-60
 
. gp40 specifically down-regulated the cell surface expression of all RAE-1 pro-
teins, but not H-60, and diminished NK cell interferon 
 
  
 
production against CMV-infected
cells. Consistent with previous findings, a m152 deletion mutant virus (
 
 
 
m152) was less viru-
lent in vivo than the wild-type Smith strain of MCMV. Treatment of BALB/c mice with a
 
neutralizing anti-NKG2D antibody before infection increased titers of 
 
 
 
m152 virus in the spleen
and liver to levels seen with wild-type virus. These experiments demonstrate that gp40 impairs
NK cell recognition of virus-infected cells through disrupting the RAE-1–NKG2D interaction.
Key words: NKG2D • RAE-1 • cytomegalovirus • NK cell • gp40
 
Introduction
 
CMVs are characterized by an impressive array of immu-
nomodulatory mechanisms. Both human CMV (HCMV)
 
*
 
and murine CMV (MCMV) encode several glycoproteins
that are involved in down-regulation of MHC class I mol-
ecules on the surface of infected cells (1, 2). These proteins
function by a diverse set of mechanisms at distinct stages in
MHC class I biosynthesis. MCMV has three gene products,
encoded by 
 
m04
 
, 
 
m06
 
, and 
 
m152
 
, which inhibit expression
of MHC class I on infected cells (1, 2). Interestingly, the
products of the 
 
m04
 
, 
 
m06
 
, and 
 
m152
 
 genes are not homol-
ogous to the HCMV class I modulators. In addition, they
down-regulate MHC class I expression by distinctly differ-
ent mechanisms, suggesting that they evolved indepen-
dently. gp34, encoded by 
 
m04
 
, complexes with class I in
the ER, is transported to the cell surface, and can inhibit
CTL activity (3, 4). gp48, the product of the 
 
m06
 
 gene,
binds to class I molecules and redirects them to the lyso-
 
some for degradation (5). 
 
m152
 
 encodes gp40, which is
involved in retention of class I complexes in ER to Golgi
intermediate compartments (6), and is a potent inhibitor of
virus-specific CTL activity (7). Although MHC class I
down-regulation can interfere with CD8
 
  
 
T cell–mediated
lysis of virus-infected cells, these cells might be more sus-
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early inducible 1 gene.T
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ceptible to NK cell cytotoxicity because NK cells preferen-
tially kill cells with low MHC class I expression (“missing
self hypothesis”; 8).
The critical role of NK cells in controlling infection by
HCMV and MCMV has long been appreciated (9, 10).
NK cells respond to target cells by integrating signals from
activating and inhibitory receptors expressed on the cell
surface. NKG2D, an activating receptor expressed on NK
cells, CD8
 
  
 
T cells, and 
 
   
 
T cells in humans and mice, as-
sociates with the adaptor protein DAP10, which contains a
YXXM motif for binding of the p85 subunit of PI-3 ki-
nase (11). In mice, an isoform of NKG2D on activated NK
cells can also associate with the immunoreceptor tyrosine-
based activation motif–bearing DAP12 adaptor protein
(12). Engagement of NKG2D by its ligands can override
inhibitory signals delivered by self–MHC class I (13, 14),
thereby reinforcing NKG2D as a potent receptor mediat-
ing NK cell activity.
Ligands for human and mouse NKG2D all share some
homology with MHC class I proteins, although they do
not associate with 
 
 
 
2-microglobulin or bind peptides. Two
families of ligands for human NKG2D are known: the
polymorphic MHC class I chain–related molecules, MICA
and MICB (15), and the UL16-binding proteins, ULBP-1,
ULBP-2, and ULBP-3 (16). Interestingly, the ULBPs were
identified by expression cloning for molecules that bind
to a HCMV glycoprotein, UL16. Ligands for murine
NKG2D include a family of retinoic acid early inducible 1
gene (RAE-1) products (RAE-1
 
 
 
, RAE-1
 
 
 
, RAE-1
 
 
 
,
RAE-1
 
 
 
, and RAE-1
 
 
 
), H-60 (a minor histocompatibility
antigen; 17, 18), and a murine UL16-binding protein-like
transcript-1 glycoprotein (19). RAE-1 is abundantly ex-
pressed in mouse embryonic tissue and in many mouse tu-
mor cell lines, but is rare in adult tissue.
Recent studies by Krmpotic et al. (20) demonstrated that
MCMV 
 
m152
 
 affects NK cell immunity against MCMV
by modulation of ligands for NKG2D. We sought to pre-
cisely identify the NKG2D ligands that are regulated by
MCMV infection. In this study, we have examined viral
modulation of RAE-1 and the functional consequences of
RAE-1–NKG2D interactions in NK cell responses to
MCMV in vitro and in vivo.
 
Materials and Methods
 
Mice.
 
BALB/c and C57BL/6 mice were purchased from The
Jackson Laboratory and Charles River, respectively. For in vivo
experiments, 6–10-wk-old female mice were used.
 
Cell Lines and Transfectants.
 
BALB/c 3T3 cells were ob-
tained from the American Type Culture Collection. 293T cells
and TpnT fibroblasts were provided by T. Kitamura (University
of Tokyo, Tokyo, Japan) and A. Hill (Oregon Health Sciences
University, Portland, OR), respectively.
Transient transfection of 293T cells was performed using Lipo-
fectamine 2000 reagent (Invitrogen). pMX-pie vector encoding
RAE-1
 
 
 
, RAE-1
 
 
 
, RAE-1
 
 
 
, RAE-1
 
 
 
, RAE-1
 
 
 
, or Flag-H-60
was mixed with an equal amount of either pMX-neo alone or
pMX-neo vector encoding m152. Lipofectamine 2000 was then
added to plasmid DNA and this mixture was incubated with 5 
 
 
 
10
 
5 
 
293T cells at 37
 
 
 
C. 48 h after transfection, cells were analyzed
by flow cytometry.
 
Viruses.
 
Wild-type MCMV Smith and a well-characterized
recombinant m152 deletion mutant strain (96.24), which has
been previously described (21), were provided by A. Hill.
 
Immunofluorescence and Flow Cytometry.
 
BALB/c 3T3 cells
were infected with Smith virus or 
 
 
 
m152 at a multiplicity of in-
fection (MOI) of 1. 72 h after infection, cells were trypsinized
and 2 
 
  
 
10
 
5 
 
cells were stained on ice for 30 min. The following
staining reagents were used to detect NKG2D ligands: mouse
NKG2D-Ig fusion protein, consisting of the extracellular domain
of mouse NKG2D fused to the Fc domain of human IgG (17);
biotinylated CX1, a rat mAb that recognizes mouse RAE-1
 
 
 
,
RAE-1
 
 
 
, and RAE-1
 
  
 
(22); and 186107, a rat mAb that recog-
nizes RAE-1
 
 
 
, RAE-1
 
 
 
, RAE-1
 
 
 
, RAE-1
 
 
 
, and RAE-1
 
 
 
.
CX1 reacts strongly with RAE-1
 
  
 
and weakly with RAE-1
 
  
 
and
RAE-1
 
 
 
, but does not bind to RAE-1
 
 
 
, RAE-1
 
 
 
, or H-60.
mAb 186107 was generated by immunizing LOU/MWS1 rats
with a soluble recombinant protein consisting of the extracellular
domain of RAE-1
 
 
 
. This antibody recognizes all RAE-1 pro-
teins, but not H-60. The Flag epitope on Flag-H-60 was de-
tected using the mouse anti-Flag M2 mAb (Sigma-Aldrich). We
previously showed that the Flag epitope tag does not interfere
with the binding of mouse NKG2D-Ig to H-60 (23). Human
MHC class I molecules were detected by staining with DX17, a
mouse anti–human pan HLA class I mAb. Mouse 
 
 
 
1-integrin
(CD29) was detected by staining with HM
 
 
 
1-1 mAb (BD Bio-
sciences), followed by biotinylated goat anti–hamster Ig and
streptavidin-PE. PE-conjugated secondary antibodies (Jackson
Immunoresearch Laboratories) were used for detection of human
Ig fusion protein and mouse and rat mAbs. Flow cytometry was
performed by using a FACSCalibur
 
® 
 
with CellQuest™ software
(Becton Dickinson) or a Guava Personal Cytometer with Guava
ViaCount and Guava Express Software (Guava Technologies).
 
TaqMan Quantitative RT-PCR.
 
Quantitative TaqMan PCR
was performed on RNA extracted from BALB/c and C57BL/6
resident peritoneal macrophages collected from 6-wk old female
mice. After harvest, macrophages were plate-adhered for 24 h, B
cells were removed by washing cells with PBS, and macrophages
were infected with Smith or 
 
 
 
m152 at an MOI of 1. Total
RNA was extracted from macrophages 48 h after MCMV infec-
tion, RNA was DNase treated, and cDNA was synthesized using
standard methods. To control for the possibility of amplifying
genomic DNA by TaqMan PCR, 25% of total RNA was used
in a cDNA synthesis reaction without reverse transcriptase. Sam-
ples without reverse transcriptase were used as templates in par-
allel with samples treated with reverse transcriptase. DNA ampli-
fied from samples without reverse transcriptase accounted for
 
 
 
10% of the total signal generated. Primer and probe sets spe-
cific for RAE-1
 
 
 
, RAE-1
 
 
 
, RAE-1
 
 
 
, RAE-1
 
 
 
, RAE-1
 
 
 
, and
H-60, previously described (22), were used with macrophage
cDNA for TaqMan PCR. All samples were normalized to the
signal generated from a housekeeping gene, HPRT. TaqMan
PCR was performed using the ABI PRISM
 
® 
 
7700 Sequence
Detection System.
 
IFN-
 
  
 
Production.
 
The levels of IFN-
 
  
 
produced by NK cells
cocultured with MCMV-infected cells were determined by a
standard ELISA using a BD Biosciences OptEIA™ Set. TpnT fi-
broblasts were infected with Smith or 
 
 
 
m152 virus at an MOI
of 1 and incubated at 37
 
 
 
C. 48 h after infection, cells were
trypsinized, fixed with fresh 4% paraformaldehyde, and washed
three times with DMEM. Effector NK cells were prepared from
C57BL/6 splenocytes and cultured for 7 d in RPMI 1640 me-T
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dium with 10% heat-inactivated FBS, 2-mercaptoethanol, and
4,000 U/ml recombinant human IL-2 provided by the National
Cancer Institute Biological Resources Branch Pre-clinical Re-
pository. Before coculture with target cells, NK cells were either
left untreated or treated for 30 min with control Ig, anti-NKG2D
mAb (CX6; reference 22), or anti-Ly49H mAb (1F8), provided
by M. Bennett (University of Texas Southwestern Medical Cen-
ter, Dallas, TX). Infected target cells were incubated with NK
cells at a 1:1 ratio for 24 h at 37
 
 
 
C. Supernatants were harvested
and used in ELISA for detection of IFN-
 
 
 
. Quantitation of IFN-
 
 
 
production was determined by averaging triplicate wells and us-
ing linear regression from a standard curve.
 
In Vivo Infection and Determination of Viral Titers.
 
Five BALB/c
mice were used in each of four experimental groups. 2 d before
infection, BALB/c mice were injected intraperitoneally with ei-
ther 100 
 
 
 
g rat anti–mouse NKG2D mAb CX5 (22) or 100 
 
 
 
g
control rat IgG (eBioscience). On the day of MCMV infection
(48 h after antibody treatment), 10
 
6 
 
PFU of Smith or 
 
 
 
m152 vi-
rus was resuspended in DMEM without serum and used to intra-
peritoneally infect mice treated with anti-NKG2D antibody or
control Ig. Spleens and livers were harvested from mice 3 d after
infection and transferred to DMEM supplemented with 10%
FBS. Liver weights were determined and organs were homoge-
nized. Tissue homogenates were centrifuged at 3,400 rpm to pel-
let cell debris. Serial dilutions were made of the supernatants and
a standard plaque assay was performed on BALB/c 3T3 cells to
determine viral titers in each organ. Viral titers for spleen are ex-
pressed as PFU per organ whereas liver viral titers were calculated
as PFU per gram tissue.
The rat anti–mouse NKG2D mAb CX5 blocks binding of
NKG2D to the RAE-1 and H-60 ligands and inhibits NKG2D-
dependent NK cell–mediated cytotoxicity against NKG2D
ligand-bearing tumors in vitro and in vivo (22). When injected in
vivo, anti-NKG2D mAb CX5 either blocked or modulated
NKG2D, but did not deplete NK cells because the frequency of
DX5
 
  
 
CD3
 
  
 
NK cells in BALB/c mice and CD3
 
  
 
NK1.1
 
  
 
NK
cells in C57BL/6 mice was not reduced compared with normal,
untreated mice (22). As a control to confirm modulation of
NKG2D on NK cells from anti-NKG2D–treated mice, spleens
from control Ig– and anti-NKG2D–treated mice were harvested
48 h after antibody injection, and expression of NKG2D on NK
cells was analyzed. In brief, total splenocytes were stained with
H-60-Ig fusion protein (consisting of the extracellular domain of
H-60 fused to human IgG1 Fc), followed by biotinylated donkey
anti–human Ig (Jackson ImmunoResearch Laboratories). Cells
were then stained with streptavidin-PE, FITC-conjugated anti-
pan NK cell mAb DX5 (VLA-2), and CyChrome-conjugated
anti-CD3
 
  
 
mAb (all from BD Biosciences). Samples were ana-
lyzed by flow cytometry.
 
Statistics.
 
For in vivo MCMV experiments, the Student’s
two-tailed 
 
t 
 
test with unequal variance was used to test the differ-
ence between arithmetic mean values of each set of PFU.
 
Results
 
 Transcriptional Induction of RAE-1 Genes by MCMV Infec-
tion.
 
The products of at least six different genes have been
identified as ligands for mouse NKG2D: RAE-1
 
 
 
, RAE-
1
 
 
 
, RAE-1
 
 
 
, RAE-1
 
 , RAE-1 , and H-60 (17, 18).
RAE-1 , RAE-1 , RAE-1 , and H-60 are expressed in
BALB/c mice (but not C57BL/6 mice) whereas RAE-1 
and RAE-1   are expressed in C57BL/6 mice (but not
BALB/c mice; unpublished data). To examine the effect of
MCMV infection on transcription of RAE-1 genes, we an-
alyzed RAE-1 and H-60 transcripts from MCMV-infected
peritoneal macrophages. Resident peritoneal macrophages
from BALB/c and C57BL/6 mice were isolated and in-
fected with the wild-type Smith strain or an m152 deletion
mutant ( m152) at an MOI of 1. Total RNA was ex-
tracted from infected macrophages 48 h after infection and
cDNA was synthesized. cDNA was then used in TaqMan
quantitative PCR to analyze RAE-1 and H-60 transcripts.
TaqMan primer and probe sets were designed to recognize
H-60 and distinguish each of the five RAE-1 gene prod-
ucts. MCMV infection transcriptionally induced RAE-1 ,
RAE-1 , and RAE-1  in peritoneal macrophages from
BALB/c mice (Fig. 1 A) and RAE-1  and RAE-1  in in-
fected C57BL/6 macrophages (Fig. 1 B). Both the wild-
type and mutant virus induced similar levels of RAE-1
transcripts in infected cells. However, neither virus induced
H-60 transcripts.
Down-regulation of NKG2D Ligands by MCMV. Given
this potent induction of RAE-1 transcription, we examined
RAE-1 protein levels on MCMV-infected cells. We in-
Figure 1. RAE-1 transcripts are induced in MCMV-infected perito-
neal macrophages. BALB/c and C57BL/6 peritoneal macrophages were
left untreated or were infected with Smith or  m152 (MOI   1). RNA
was extracted from cells 48 h after infection and cDNA was synthesized.
TaqMan quantitative PCR was performed on BALB/c cDNA using
primer/probe sets specific for RAE-1 , RAE-1 , RAE-1 , or H-60 (A),
and on C57BL/6 cDNA with primer/probe sets specific for RAE-1  and
RAE-1  (B). Signals generated from each sample were normalized to
HPRT signals from each set of cDNA. Data are expressed as the fold in-
duction of transcription in infected cells compared with uninfected cells.
Standard deviations of triplicate samples were  1%. Results shown are
representative of three independent experiments.T
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fected BALB/c 3T3 cells, a permissive cell line from
BALB/c mice that constitutively expresses RAE-1 on the
cell surface, with wild-type virus at an MOI of 1. 72 h after
infection, cells were stained for surface expression of
NKG2D ligands using two different staining reagents: a
mouse NKG2D-Ig fusion protein (17) and CX1, a mAb
that recognizes RAE-1 , RAE-1 , and RAE-1   (22).
MCMV infection resulted in dramatic down-regulation of
NKG2D ligands compared with uninfected cells when ana-
lyzed by flow cytometry using NKG2D-Ig or the anti–
RAE-1–specific mAb CX1 (Fig. 2 A). Thus, RAE-1 ap-
peared to be a prominent target for modulation by virus
infection. To assess the specificity of down-regulation of
NKG2D ligands, infected cells were also stained with anti–
 1-integrin, which was unaffected by MCMV infection
(Fig. 2 B). These experiments demonstrate that infection
with MCMV results in specific down-regulation of RAE-1.
One viral gene product, gp40, encoded by the MCMV
m152 gene, has been shown to down-regulate MHC class I
(6) as well as an undefined NKG2D ligand (20). We in-
fected BALB/c 3T3 cells with wild-type or  m152 mutant
virus and stained infected cells with the mouse NKG2D-Ig
fusion protein or anti–RAE-1 mAb. Interestingly, cells in-
fected with  m152 down-regulated expression of NKG2D
ligands much less efficiently than wild-type virus (Fig. 2 A).
This finding is consistent with that of Krmpotic et al. (20)
who showed, using an NKG2D tetramer, that  m152-
infected cells maintained expression of NKG2D ligands
compared with strong down-regulation observed in cells
infected with wild-type virus. These experiments dem-
onstrate that gp40 modulates expression of ligands for
NKG2D in addition to down-regulating MHC class I pro-
teins on the surface of MCMV-infected cells.
gp40 Down-regulates RAE-1 , RAE-1 , RAE-1 , RAE-
1 , and RAE-1 , but not H-60. Studies of MHC class I
down-regulation by gp40 have revealed an allele-specific
preference, with certain MHC class I haplotypes affected
more than others (24). To determine whether there are dif-
ferential effects of gp40 on the five different RAE-1 pro-
teins, we transiently transfected either m152 cDNA or a
control empty vector, along with RAE-1 , RAE-1 ,
RAE-1 , RAE-1 , or RAE-1  cDNA into human 293T
cells. Mouse RAE-1 cDNA were encoded by a vector that
also expressed green fluorescent protein (GFP [internal ri-
bosome entry site (IRES)-GFP]) whereas m152 cDNA was
encoded by a non-GFP vector. 48 h after transfection of
RAE-1 cDNA with or without m152 cDNA, cells were
examined for mouse RAE-1 expression by staining with
anti–RAE-1 mAbs (CX1 mAb for detection of RAE-1 ,
RAE-1 , and RAE-1 , or 186107 mAb for detection of
RAE-1  and RAE-1 ). Gating on the GFP  population al-
lowed us to analyze only RAE-1–expressing cells. Trans-
fection of RAE-1 cDNA with a control empty vector re-
sulted in high mouse RAE-1 expression as determined by
anti–RAE-1 mAb staining (Fig. 3 A). In contrast, cotrans-
fection of m152 along with any of the RAE-1 cDNAs ( ,
 ,  ,  , or  ) resulted in a substantial down-regulation. All
of the RAE-1 proteins were found to be susceptible to the
impact of gp40, in particular RAE-1 . As a control, the
transfected human cells were also stained with an anti-HLA
class I mAb. Anti–human HLA staining of human 293T
cells was unaffected by m152 transfection (Fig. 3 B), sug-
gesting that m152 down-regulation of RAE-1 proteins was
specific and did not affect human MHC class I expression.
In a similar 293T transfection system, the effect of gp40
on H-60 expression was analyzed. Due to the lack of an
antibody against H-60, a Flag epitope tag was inserted
onto the 5  terminus of the H-60 cDNA and expressed
by using an IRES-GFP vector. Flag-H-60 cDNA was
cotransfected with m152 cDNA or with a control vector
into 293T cells. Cells were examined for H-60 expression
by anti-Flag mAb staining 48 h after transfection. m152
expression had little or no effect on levels of Flag-H-60
(Fig. 3 A). Cotransfection of m152 and native H-60 with-
out the Flag epitope tag and staining with mouse
NKG2D-Ig fusion protein also indicated that m152 did
Figure 2. MCMV infection results in down-reg-
ulation of NKG2D ligands. BALB/c 3T3 cells were
infected with wild-type MCMV (Smith) or  m152
(MOI   1). 72 h after infection, infected cells were
stained with control Ig (cIg), NKG2D-Ig fusion
protein, or anti–RAE-1 mAb (CX1; A). As a con-
trol, cells were stained with anti– 1-integrin (B).
Representative results are shown based on similar
findings in three independent experiments.T
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not effect expression of H-60 (unpublished data). Thus, al-
though gp40 potently down-regulates RAE-1 , RAE-1 ,
RAE-1 , RAE-1 , and RAE-1 , gp40 does not appear to
influence H-60 expression.
MCMV Infection Induces NKG2D-mediated IFN-   Pro-
duction by NK Cells. To evaluate the functional conse-
quences of RAE-1 down-regulation by gp40, we analyzed
IFN-  production by NK cells cocultured with MCMV-
infected cells. For this experiment, TpnT cells (mouse em-
bryonic fibroblasts derived from C57BL/6 mice) were used
for infection. These cells stained positively with the
NKG2D-Ig fusion protein (Fig. 4 A), indicating that they
constitutively expressed relatively high levels of RAE-1
proteins. TpnT fibroblasts were infected with wild-type or
 m152 mutant virus at an MOI of 1, and 72 h after infec-
tion cells were trypsinized and fixed with 4% paraformalde-
hyde. Infected cells and uninfected control cells were then
cocultured with IL-2–activated C57BL/6 NK cells at a 1:1
ratio for 24 h in the presence or absence of blocking anti-
bodies against mouse NKG2D, mouse Ly49H, or a control
mAb. As additional controls, NK cells were cultured alone
to determine background production of IFN- , or cul-
tured with IL-12 to stimulate maximal IFN-  production.
Supernatants were collected from the cocultured cells and
analyzed by ELISA for IFN- . Coculture of NK cells with
uninfected cells generated low amounts of IFN-  compara-
ble to levels of IFN-  produced by NK cells alone (Fig. 4
B). In contrast, coculture with virus-infected cells, particu-
larly  m152-infected cells, resulted in high IFN-  produc-
tion, which was partially blocked by culturing NK cells
with anti-NKG2D mAb. Consistent with previous findings
(25), anti-Ly49H mAb also substantially blocked IFN- 
production. Blocking antibodies did not effect IFN-  pro-
duction by NK cells cultured with IL-12. These data dem-
onstrate that modulation of RAE-1 molecules by gp40 has
functional consequences for NK cell function: the presence
of RAE-1 molecules on  m152-infected cells allows for
NKG2D-dependent activation of NK cell IFN-  produc-
tion. The ability to block this effect by addition of anti-
NKG2D antibody highlights the potential significance of
RAE-1–NKG2D interactions for NK cell activation during
virus infection.
m152 Contributes to the Virulence of MCMV by Disrupting
NKG2D Functions. Based on the in vitro experiments de-
scribed above, gp40-mediated down-regulation of RAE-1
molecules during MCMV infection seemed to impair the
ability of NK cells to respond to MCMV-infected cells. To
examine the physiological relevance of these findings, we
evaluated the role of RAE-1–NKG2D interactions during
viral infection in MCMV-susceptible BALB/c mice. In
BALB/c mice, which lack the Ly49H receptor, the impor-
tance of NKG2D during MCMV infection could be inves-
tigated in the absence of the dominant effects of Ly49H in
C57BL/6 mice (26), which may obscure the effects of gp40
Figure 3. gp40 selectively down-regulates RAE-1
proteins but not H-60. RAE-1 cDNAs or H-60
cDNA (with a 5  Flag epitope tag) were cotrans-
fected with a control empty vector, or with a vec-
tor encoding the m152 gene into human 293T
cells. RAE-1 and H-60 cDNAs were encoded on
vectors carrying an IRES-GFP whereas a non-GFP
vector was used for m152 cDNA and for the con-
trol vector. 48 h after transfection, cells were
stained with control Ig (cIg), biotinylated anti–
RAE-1 mAb CX1 (recognizing RAE-1 , RAE-1 ,
and RAE-1 ), rat anti–RAE-1 mAb 186107 (rec-
ognizing RAE-1  and RAE-1 ), or anti-Flag (A).
As a control, cells were stained with anti–human
HLA class I mAb DX17 (B). Mean fluorescence in-
tensities (MFI) are shown to the right of each dot
plot. MFI in A reflect RAE-1 or H-60 expression,
calculated based on gated, GFP  cells. MFI of hu-
man MHC class I expression (B) were determined
based on the total cell population. Results are rep-
resentative of similar findings in three independent
experiments.T
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(20). 2 d before infection, BALB/c mice were treated in-
traperitoneally with a blocking anti-NKG2D mAb (CX5)
or an isotype-matched control antibody. Treatment of
mice with anti-NKG2D blocked or modulated expression
of the NKG2D receptor, but did not deplete NK cells, as
determined by detection of normal frequencies of DX5 
CD3  NK cells in the anti-NKG2D mAb-treated mice
(22). On the day of infection, NKG2D blocking was veri-
fied by staining splenocytes from anti-NKG2D– or control
Ig–treated mice with an H-60-Ig fusion protein. As shown
in Fig. 5 A, treatment of mice with anti-NKG2D resulted
in decreased NKG2D expression on DX5  CD3  spleno-
cytes. For MCMV infection, 106 PFU of Smith or  m152
virus were injected intraperitoneally into anti-NKG2D– or
control Ig–treated mice. 3 d after infection, spleens and liv-
ers were harvested from infected mice and homogenized.
Virus was extracted from organ homogenates and used in a
plaque assay to determine viral titers in each organ.
As depicted in Fig. 5 B, in spleens of control Ig–treated
mice,  m152 infection resulted in significantly lower viral
titers than Smith infection (P   0.05). It is likely that this is
due to the expression of RAE-1 on the surface of  m152-
infected cells, which facilitates NK cell–mediated clearance.
Consistent with this interpretation, in the anti-NKG2D–
Figure 4. MCMV infection costimulates NK cell IFN- 
production through NKG2D. (A) TpnT cells were stained
with a control antibody or with the NKG2D-Ig fusion
protein. (B) TpnT cells were infected with Smith or
 m152 virus (MOI   1) and cocultured with IL-2–acti-
vated C57BL/6 NK cells. Before coculture, NK cells were
left untreated or treated with control Ig, anti-NKG2D
(CX6), or anti-Ly49H (IF8), as indicated. As controls, NK
cells were also cultured alone or in the presence of IL-12.
Standard deviations of triplicate samples were  1%. This
experiment was performed several times with comparable
results.
Figure 5. Virulence of  m152 virus is restored by block-
ing NKG2D in vivo. (A) BALB/c mice were injected intra-
peritoneally with control Ig or anti-NKG2D mAb (CX5).
As a control to ensure NKG2D modulation, spleens were
harvested from control Ig– and anti-NKG2D–treated ani-
mals 48 h after antibody treatment. Total splenocytes were
stained with H-60-Ig fusion protein (to detect NKG2D),
biotinylated goat anti–human Ig, streptavidin-PE, FITC-
conjugated anti-pan NK cell mAb DX5 (VLA-2), and Cy-
Chrome-conjugated anti-CD3  mAb. Overlaid histograms
represent H-60-Ig staining of DX5  CD3  cells from con-
trol Ig– or anti-NKG2D–treated mice. Although equivalent
frequencies of DX5  CD3  NK cells were present in con-
trol Ig– and anti-NKG2D mAb–treated mice, NKG2D was
modulated on NK cells of mice treated with anti-NKG2D
mAb in vivo. (B) 48 h after antibody treatment, mice were
infected with 106 PFU of Smith or  m152. 3 d after infec-
tion, mice were killed and spleens and livers were harvested.
Plaque assays were performed on organ homogenates to de-
termine viral titers in spleen and liver. Five mice were used
per group. Two independent experiments were performed
with comparable results; a representative experiment is
shown. Statistical analysis was performed using the Student’s
two-tailed t test with unequal variance.T
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treated mice infected with  m152, viral titers in the spleen
and liver were comparable to titers in mice infected with
wild-type virus, which down-regulates RAE-1 on infected
cells. During infection with wild-type virus, anti-NKG2D
mAb treatment consistently resulted in a slight, but not sig-
nificant, increase in viral titers, as compared with control
Ig–treated mice. This is not unexpected because cells in-
fected with wild-type virus may have very little RAE-1 on
the cell surface, due to its down-regulation by gp40. Col-
lectively, these experiments suggest that gp40, encoded by
m152, may provide a means of MCMV escape from NK
cell recognition at early times after infection.
Discussion
In this study, we have precisely defined another target of
the MCMV immunomodulatory gene product gp40. In
addition to MHC class I down-regulation (6), gp40 selec-
tively prevents cell surface expression of RAE-1 and im-
pairs NK cell recognition of virus-infected cells. MCMV
gp40 does not reduce transcription of the RAE-1 genes,
but appears to prevent expression of RAE-1 glycoproteins
on the cell surface by a posttranscriptional mechanism. The
ability of gp40 to affect expression of both conventional
H-2 class I and the RAE-1 proteins is remarkable, consid-
ering that RAE-1 shares such limited amino acid homol-
ogy with MHC class I ( 20%; 17, 18). RAE-1 glycopro-
teins lack an  3 domain, do not bind peptides, do not
associate with  2-microglobulin, and are glycosylphos-
phatidylinositol-anchored proteins. Like MHC class I,
though, RAE-1 glycoproteins have an extracellular do-
main containing  1 and  2 helices, which are believed to
be the sites of gp40 interaction with MHC class I (27). Ad-
ditional studies will reveal whether gp40 binds to RAE-1
and H-2 in a similar fashion.
Although gp40 impacts all five known RAE-1 mole-
cules, RAE-1 , RAE-1 , RAE-1 , RAE-1 , and RAE-1 ,
interestingly it does not seem to affect surface expression of
H-60, another cell surface MHC class I–like glycoprotein
with  1 and  2 domains that binds to NKG2D with high
affinity (28). Although the RAE-1 proteins share a high
degree of similarity (94–98% identical), H-60 has only
 25% homology to the RAE-1 family (17, 18). It is
tempting to speculate that MCMV may have evolved gp40
to bind the RAE-1 proteins, but not H-60, because of se-
lective pressure exerted by the immune system. The abun-
dance of RAE-1 RNA in infected cells may have driven
the evolution of a viral protein that can specifically prevent
cell surface expression of RAE-1 glycoproteins in addition
to conventional H-2 class I. Because H-60 transcription
does not appear to be induced by MCMV infection of
macrophages, gp40 binding to H-60 proteins may confer
little selective advantage to the virus.
A recent paper by Krmpotic et al. (20) also demonstrated
down-regulation of NKG2D ligands by gp40. In an effort
to address whether the susceptibility of BALB/c mice to
MCMV is caused by virus-induced subversion of NK cell–
mediated immunity, these investigators examined the abil-
ity of two MCMV-encoded MHC class I modulators, gp40
and gp48, to regulate NK cell activation. They found that
the presence of gp40 during viral infection resulted in di-
minished NK cell control of MCMV in the lungs of
BALB/c, but not C57BL/6 mice. Thus, this study con-
vincingly demonstrated the importance of gp40 in viral
pathogenesis in vivo in BALB/c mice using an m152 dele-
tion mutant virus (20). Based on previous evidence that
BALB/c, but not C57BL/6 mice can express H-60 (29),
these investigators proposed that gp40 might preferentially
affect expression of H-60. However, no evidence was pro-
vided to verify that H-60 is present in MCMV-infected
cells or that gp40 can directly modulate H-60 expression.
In addition to differences in H-60 expression, C57BL/6
and BALB/c mice differentially express RAE-1 genes:
RAE-1 , RAE-1 , and RAE-1  are expressed in BALB/c
but not in C57BL/6 mice whereas RAE-1  and RAE-1 
are expressed in C57BL/6 but not in BALB/c mice.
Therefore, the different immune responses to MCMV ob-
served in BALB/c compared with C57BL/6 mice must
take into account the expression of different RAE-1 genes
and different activating Ly49 receptors, as well as other
background differences, in these two mouse strains.
Immunity to MCMV requires both the action of NK
cells and cytotoxic T cells (CTL), both of which express
NKG2D. In this regard, it is interesting that gp40 has
evolved to block cell surface expression of conventional
MHC class I and RAE-1, a mechanism that might be par-
ticularly effective in evading detection by CTL. Our
present studies have focused on the early NK cell–mediated
events after viral infection. We have shown that transcrip-
tion of RAE-1 genes was induced by MCMV infection of
primary cells, but that viral gp40 efficiently prevented cell
surface expression of the RAE-1 glycoproteins. The physi-
ological importance of this was revealed by comparing the
virulence of wild-type and  m152 virus in MCMV-sus-
ceptible BALB/c mice. Consistent with previous findings
(20), the m152-deficient virus showed reduced virulence
during in vivo infection of BALB/c mice, possibly due to
the elimination of RAE-1–bearing virus-infected cells by
an NKG2D-dependent mechanism. This hypothesis was
tested by treating BALB/c mice with anti-NKG2D mAb
before infection. Treatment of mice with anti-NKG2D
mAb restored viral titers of  m152-infected mice to levels
comparable to wild-type virus-infected mice. These find-
ings support an important role for m152 in viral evasion of
NKG2D-dependent immune surveillance. Blockade of
NKG2D in mice infected with wild-type virus showed
only modest effects on viral titers early after infection, a re-
sult predicted if gp40 efficiently suppresses RAE-1 expres-
sion in infected cells.
The ability of gp40 to down-regulate MHC class I has
been clearly implicated in evasion of CTL-mediated im-
munity late after viral infection. However, during the
early stages of infection dominated by NK cell immunity,
loss of inhibitory MHC class I should render virus-infected
cells more susceptible to NK cell attack. In mice infected
with m152-deficient virus, which does not efficientlyT
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block H-2 expression, however, viral titers in the spleen
were in fact lower than in mice infected with wild-type
virus at early times after infection. As previously noted,
blockade of NKG2D restored virulence of the m152-defi-
cient virus, suggesting that NKG2D may permit NK cells
to recognize and eliminate virus-infected cells, even if
MHC class I is expressed on the infected cells. Similarly,
recent studies have shown that NK cells are capable of re-
jecting tumors bearing MHC class I if they express
NKG2D ligands (13, 14).
Based on experiments with gene-deficient mice, it was
found that a perforin-dependent NK cell–mediated cyto-
toxicity is critical for control of MCMV in the spleen, but
in the liver, NK cell–derived IFN-   is a predominant
mechanism of viral clearance (30). We have shown that
C57BL/6 NK cells cultured with wild-type or  m152-
infected cells produced IFN-  by a mechanism that is at
least in part dependent on NKG2D. We have also shown
that IFN-  produced by C57BL/6 NK cells cocultured
with virus-infected cells is largely due to Ly49H-dependent
activation because this effect is blocked by anti-Ly49H an-
tibody. Ly49H, expressed in C57BL/6 but not BALB/c
mice, recognizes m157, a MCMV-encoded MHC class
I–like glycoprotein that is expressed on the surface of virus-
infected cells (25, 31). Engagement of Ly49H by m157 re-
sults in NK cell activation and contributes to NK cell pro-
tection against MCMV in C57BL/6 mice (26, 32, 33).
Our in vitro results imply that NKG2D may costimulate
Ly49H-dependent NK cell activation, thereby providing
more efficient immunity in MCMV-resistant C57BL/6
mice. However, it appears that Ly49H is the dominant
player in this response in vivo because previous studies
failed to demonstrate a substantial difference in viral titers
in C57BL/6 mice infected with wild-type or m152 dele-
tion mutant viruses (20). Interestingly, we were unable to
observe IFN-  production by BALB/c NK cells in vitro in
response to MCMV-infected BALB/c-derived fibroblasts
(unpublished data). These data suggest that Ly49H might
be necessary for robust IFN-  production in response to
MCMV infection.
In summary, by down-regulating expression of RAE-1
molecules, thereby impairing NK cell recognition of virus-
infected cells, gp40 may effectively undermine the early
NK cell response to MCMV infection. This mechanism of
immune evasion likely contributes to the complex inter-
play of viral persistence and NK cell protection inherent to
herpesvirus infections. 
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